Page last updated: 2024-10-16

carnitine and Multiple Sclerosis, Relapsing-Remitting

carnitine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 1 studies

Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Teixeira, CF1
Azzolin, VF1
Rodrigues Dos Passos, G1
Turra, BO1
Alves, AO1
Bressanim, ACM1
Canton, LEL1
Vieira Dos Santos, AC1
Mastella, MH1
Barbisan, F1
Ribeiro, EE1
Duarte, T1
Duarte, MMMF1
Bonotto, NCA1
Sato, DK1
da Cruz, IBM1

Other Studies

1 other study available for carnitine and Multiple Sclerosis, Relapsing-Remitting

ArticleYear
A coffee enriched with guarana, selenium, and l-carnitine (GSC) has nutrigenomic effects on oxi-inflammatory markers of relapsing-remitting multiple sclerosis patients: A pilot study.
    Multiple sclerosis and related disorders, 2023, Volume: 71

    Topics: Carnitine; Coffee; Cytokines; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; N

2023